David R. Trauber conducts research on a range of serious medical conditions, especially those that affect patients with weakened immune systems, such as those with HIV/AIDS and cancer. His work involves examining unusual complications that arise from these diseases, such as severe hypercalcemia in AIDS patients or the rare lung involvement in lymphoma. Dr. Trauber investigates how these conditions manifest, including serious infections, hormonal imbalances, and rare cancers, which can greatly affect diagnosis and treatment strategies. He also researches potential therapies and interventions that may improve patient outcomes.
Key findings
In his study on hypercalcemia, Dr. Trauber found that a patient with AIDS had calcium levels of 16.49 mg/dL, significantly above the normal range, highlighting the need for careful monitoring of calcium levels in AIDS patients.
One patient with lung consolidation due to lymphoplasmacytic lymphoma showed an exceptionally high IgM protein level of 1491 mg/dL, indicating a critical condition often overlooked in lung examinations.
The prevalence of adrenal insufficiency among sickle cell disease patients was found to be 19.4%, showing that these patients are over 2,375 times more likely to develop this condition compared to the general population.
Frequently asked questions
Does Dr. Trauber study AIDS-related complications?
Yes, he studies complications such as severe hypercalcemia in AIDS patients.
What types of lymphoma does Dr. Trauber research?
He focuses on rare presentations of lymphomas, including lymphoplasmacytic lymphoma and gastric marginal zone B cell lymphoma.
Is Dr. Trauber's work relevant for patients with sickle cell disease?
Absolutely, his research highlights the high prevalence of adrenal insufficiency among sickle cell disease patients.
What treatments has Dr. Trauber investigated for weight loss in HIV patients?
He has examined leptin levels in HIV-infected patients and found that leptin does not significantly contribute to weight loss.
Does Dr. Trauber work on vaccine development?
Yes, he has studied modified vaccinia virus mutants that could be used in developing safer vaccines against HIV.
Publications in plain English
Lung consolidation as a rare presentation of lymphoplasmacytic lymphoma with extramedullary Waldenström's macroglobulinemia.
2018
Journal of community hospital internal medicine perspectives
Abdulfattah O, Rahman EU, Bhattarai B, Dahal S, Alnafoosi Z +3 more
Plain English This study focused on a 73-year-old woman who developed lung issues due to a rare form of lymphoma called lymphoplasmacytic lymphoma (LPL) with lung involvement. She first experienced a cough and significant weight loss, and later tests revealed a very high level of a specific protein called IgM in her blood (1491 mg/dL, where the normal range is 26-217 mg/dL), indicating a serious condition related to her lymphoma. This research highlights the need for doctors to recognize that LPL can affect the lungs, which is uncommon, but crucial for accurate diagnosis and treatment.
Who this helps: This information benefits doctors treating patients with lymphoma, particularly those showing unusual symptoms.
Severe hypercalcemia in a patient with extrapulmonary: granuloma or immune reconstitution inflammatory syndrome? First case ofpresenting as retroperitoneal lymphadenopathy with severe hypercalcemia: a case report and literature review.
2018
Journal of community hospital internal medicine perspectives
Abdulfattah O, Rahman EU, Shweta F, Datar P, Alnafoosi Z +4 more
Plain English This study examined a 56-year-old man with AIDS who experienced severe hypercalcemia (very high calcium levels in the blood) and altered mental status due to a nontuberculous mycobacterium infection. His calcium levels reached 16.49 mg/dL, far above the normal range of 8.9-10.3 mg/dL, and he had significant lymph node swelling in his abdomen. The findings highlight the importance of monitoring calcium levels in AIDS patients, particularly when they start treatment, to prevent complications associated with these infections.
Who this helps: This helps patients with AIDS and their doctors.
Advanced Gastrointestinal Diffuse Large B-Cell Lymphoma Presenting with Obstructive Jaundice and Very High CA 19-9 Level Mimicking Pancreatic Adenocarcinoma.
High prevalence of adrenal insufficiency in patients with sickle cell disease: results from a community hospital in the U.S.
2013
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Makino J, Ndzengue A, Adekolujo S, Tipu A, Dogar UM +6 more
Plain English This study looked at how common adrenal insufficiency (AI) is among patients with sickle cell disease (SCD) at a hospital in the U.S. It found that 19.4% of SCD patients tested positive for AI, compared to only 0.008% in the general population, showing that SCD patients are 2,375 times more likely to develop this condition. Understanding this high prevalence is important because it can lead to better monitoring and treatment for SCD patients who may be at risk for AI.
Who this helps: This helps patients with sickle cell disease and their healthcare providers.
Gastric marginal zone B cell lymphoma of the duodenum.
2011
Case reports in gastroenterology
Ndzengue A, Khurana R, Mora M, Rafal RB, Trauber D +3 more
Plain English This study looked at a rare type of cancer called gastric marginal zone B cell lymphoma, specifically in the small intestine, which usually affects younger people and is often linked to malabsorption. They reported a case of a 73-year-old woman who experienced severe vomiting and stomach swelling, but unlike typical cases, she did not have malabsorption issues. After diagnosing her with this rare lymphoma through an endoscopy, she saw improvement in her symptoms after undergoing radiotherapy.
Who this helps: This research helps doctors understand how this type of lymphoma can present in older patients.
Serum leptin concentration in patients infected with human immunodeficiency virus.
1999
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Nowak D, Peesapati SK, Jeet A, Moktan S, Kudej M +3 more
Plain English This study looked at leptin levels, a hormone that helps regulate body weight, in 94 HIV-infected patients to see if it was linked to weight loss from HIV. The average leptin level was 7.0 ng/mL, with women having higher levels (10.0 ng/mL) than men (5.0 ng/mL). The researchers found that leptin levels were mostly influenced by body weight and did not support the idea that leptin significantly contributes to weight loss in HIV patients.
Who this helps: This information benefits doctors treating patients with HIV, particularly in understanding weight management.
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses.
1989
Proceedings of the National Academy of Sciences of the United States of America
Rodriguez D, Rodriguez JR, Rodriguez JF, Trauber D, Esteban M
Plain English Researchers studied a modified version of a virus called vaccinia, which has been genetically altered to be safer. They found that this virus, known as 48-7, can be engineered to carry parts of the HIV virus, which helps the body produce antibodies against HIV without causing harm. This is important because it shows that the modified virus can be used to create safer vaccines that stimulate the immune system effectively.
Who this helps: This benefits patients at risk for HIV and doctors developing safer vaccines.
A 66-base pair insert bridges the deletion responsible for a mouse model of beta-thalassemia.
1986
The Journal of biological chemistry
Goldberg SZ, Kuebbing D, Trauber D, Schafer MP, Lewis SE +2 more
Plain English This study looked at a specific genetic change in mice that causes beta-thalassemia, a blood disorder. Researchers identified a 66-base pair section of DNA that helps connect a missing part of a gene responsible for making hemoglobin. They found that regular mice have a similar piece of DNA, which could help understand and potentially treat this condition in humans.
Who this helps: Patients with beta-thalassemia and their doctors.
Humoral factor that specifically regulates factor X levels in rabbits (coagulopoietin-X).
1979
The Journal of clinical investigation
Trauber D, Hawkins K, Karpatkin M, Karpatkin S
Plain English The study examined a substance called coagulopoietin-X in rabbits that had low levels of a blood-clotting factor known as Factor X. When this substance was injected into rabbits, it increased their Factor X levels by about 120-150% more than normal, indicating that coagulopoietin-X plays a special role in raising Factor X levels without simply increasing the amount of proteins produced. This is important because understanding how to boost Factor X could help improve treatments for bleeding disorders.
Who this helps: This helps patients with bleeding disorders and their doctors.